Silo Pharma extends license agreement with University of Maryland through Sept 2023, with option to Dec 2023

Silo Pharma, Inc.

Term of Commercial Evaluation and License Agreement extended to September 30, 2023.
Company may further extend to December 31, 2023 by paying $2,500 fee and providing notice by August 31, 2023.
Amendment executed June 28, 2023; fee creditable against future patent expenses if master license signed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.